Advisors and Investor contacts

Registrar

Capita Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU

ADR Depositary Bank

BNY Mellon Shareowner Services
PO BOX 30170
College Station
TX 77842-3170
USA

Company Secretary and Registered Office

100 Berkshire Place
Wharfedale Road
Winnersh
Berkshire
RG41 5RD
England

Chartered Accountants and Statutory Auditors

PricewaterhouseCoopers LLP
One Reading Central 
23 Forbury Road
Reading
Berkshire
RG1 3JH

Solicitors

Covington & Burling LLP
265 Strand
London
WC2R 1BH

Nominated Advisors and Broker

Canaccord Genuity Limited
88 Wood Street
London
EC2V 7QR

Joint Broker

Shore Capital Stockbrokers Limited
Bond Street House
14 Clifford Street
London
W1S 4JU

Public Relations

FTI Consulting LLP
200 Aldersgate
Aldersgate Street
London EC1A 4HD

Latest News

Vernalis plc receives a $2 million milestone payment from one of its drug discovery collaborations

Vernalis plc announced today that it has received a $2m milestone under one of its existing research collaborations to discover novel small molecules against an undisclosed target utilising Vernalis' fragment and structure-based drug discovery platform.

 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch